HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum 17-hydroxypregnenolone and 17-hydroxypregnenolone sulfate concentrations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Abstract
Serum concentrations of 17-hydroxypregnenolone, 17-hydroxypregnenolone sulfate and 17-hydroxyprogesterone were measured simultaneously in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, using a combined radioimmunoassay method. All these precursor steroids were found to be markedly elevated in the sera of untreated patients with a salt-losing form of the disease, whereas, in untreated patients with a simple virilizing form, only the concentration of unconjugated steroids was increased and the 17-hydroxypregnenolone sulfate concentration remained within the normal range. Among the patients with a salt-losing form under maintenance therapy, these steroids were all still significantly increased in those on insufficient control, whereas only 17-hydroxyprogesterone was significantly but slightly increased in those on adequate control. Although the mechanism whereby the serum 17-hydroxypregnenolone sulfate concentration is not increased in the untreated simple virilizers is unknown, both a milder degree of 21-hydroxylase deficiency and a role of 17-hydroxypregnenolone sulfate in adrenal steroid production as a kind of supplier are suggested as possible explanations, especially in the neonatal period and early infancy. Thus, this study showed the serum concentrations of 17-hydroxypregnenolone and its sulfate together with 17-hydroxyprogesterone in patients with 21-hydroxylase deficiency in various conditions.
AuthorsK Shimozawa, S Saisho, J Yata, A Kambegawa
JournalEndocrinologia japonica (Endocrinol Jpn) Vol. 35 Issue 1 Pg. 11-8 (Feb 1988) ISSN: 0013-7219 [Print] Japan
PMID3260857 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hydroxyprogesterones
  • 17-hydroxypregnenolone sulfate
  • 17-alpha-Hydroxypregnenolone
  • 17-alpha-Hydroxyprogesterone
  • Steroid Hydroxylases
  • Cortisone
  • Hydrocortisone
Topics
  • 17-alpha-Hydroxypregnenolone (analogs & derivatives, blood)
  • 17-alpha-Hydroxyprogesterone
  • Administration, Oral
  • Adolescent
  • Adrenal Hyperplasia, Congenital (drug therapy, etiology, metabolism)
  • Aging
  • Child
  • Child, Preschool
  • Cortisone (analogs & derivatives, therapeutic use)
  • Humans
  • Hydrocortisone (therapeutic use)
  • Hydroxyprogesterones (blood)
  • Infant
  • Infant, Newborn
  • Radioimmunoassay
  • Steroid Hydroxylases (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: